238 related articles for article (PubMed ID: 11341514)
1. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
Fernández MA; Andreu R; Fortea JM; Aznar J
Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
[No Abstract] [Full Text] [Related]
2. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Rombouts EK; Rosendaal FR; van der Meer FJ
Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulant therapy: a precipitating factor in the pathogenesis of cholesterol embolization?
Nevelsteen A; Kutten M; Lacroix H; Suy R
Acta Chir Belg; 1992; 92(1):33-6. PubMed ID: 1553847
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
Katona A; Márk L
Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
[TBL] [Abstract][Full Text] [Related]
5. Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.
Trailokya A; Hiremath JS; Sawhney J; Mishra YK; Kanhere V; Srinivasa R; Tiwaskar M
J Assoc Physicians India; 2016 Feb; 64(2):88-93. PubMed ID: 27730796
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
Mazokopakis EE; Vrentzos GE; Ganotakis ES
Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
[TBL] [Abstract][Full Text] [Related]
7. [Thrombosis of the central vein of the retina during anticoagulant treatment].
Rosselet E
Bull Mem Soc Fr Ophtalmol; 1976; 88():362-4. PubMed ID: 1029620
[No Abstract] [Full Text] [Related]
8. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
Fernández MA; Romá E
Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
[No Abstract] [Full Text] [Related]
9. [Anticoagulant therapy in myocardial infarction. An evaluation of the present state].
Bjerkelund C
Nord Med; 1971 Jul; 85(26):789-99. PubMed ID: 4997493
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with anticoagulant long term treatment of predominantly cardiologic patients].
Kubicek F; Praschl E
Wien Klin Wochenschr; 1968 Nov; 80(44):813-9. PubMed ID: 4974107
[No Abstract] [Full Text] [Related]
11. [Acute hemorrhagic pancreatitis in the course of anticoagulant therapy. (Description of a case)].
Nicora E
Pathologica; 1966; 58(863):243-7. PubMed ID: 5990357
[No Abstract] [Full Text] [Related]
12. [Hemarthroses complicating anticoagulant therapy (heparin, oral anticoagulants)].
Gerster JC; Wauters JP; Waldburger M; Saudan Y
Schweiz Med Wochenschr; 1977 Aug; 107(33):1170-2. PubMed ID: 897653
[TBL] [Abstract][Full Text] [Related]
13. The effect of acenocoumarol on hemorheological parameters.
Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term anticoagulant therapy on the prognosis of myocardial infarction.
Matsuda T
Jpn Circ J; 1967 Nov; 31(11):1602-6. PubMed ID: 5630882
[No Abstract] [Full Text] [Related]
15. [Comparative study of low-dose heparin and syncumar therapy in the prevention of thromboembolism in myocardial infarct].
Brenner F; Szentcsiki M; Varga J; Kocsis J; Gajda J
Orv Hetil; 1981 Jul; 122(27):1655-6. PubMed ID: 7290674
[No Abstract] [Full Text] [Related]
16. Rosuvastatin-acenocoumarol interaction.
Mondillo S; Ballo P; Galderisi M
Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
[TBL] [Abstract][Full Text] [Related]
17. [Secondary anticoagulant prophylaxis with low molecular heparins or oral anticoagulants and bone mineral density].
Wawrzyńska L; Przedlacki J; Hajduk B; Tomkowski W; Fijałkowska A; Ostrowski K; Torbicki A
Pol Arch Med Wewn; 2000 Nov; 104(5):769-77. PubMed ID: 11434089
[TBL] [Abstract][Full Text] [Related]
18. [Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].
Kropacheva ES; Panchenko EP; Ataullakhanova DM
Klin Med (Mosk); 2005; 83(1):24-7. PubMed ID: 15759486
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.
Roldán-Schilling V; Marín-Ortuño F; Marco-Vera P; Sogorb-Garri F
Haematologica; 2000 Jul; 85(7):778-80. PubMed ID: 10897143
[No Abstract] [Full Text] [Related]
20. [Recurrence of myocardial infarct after discontinued administration of oral anticoagulants: fatal rebound for certain risk groups?].
Beer J; Schlup P
Schweiz Med Wochenschr; 1986 Apr; 116(14):429-31. PubMed ID: 3961458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
